Samsung Biologics to invest USD 4.8 billion in new Songdo bio campus
Dec 02, 2025
Samsung Biologics has announced a massive investment of 7 trillion won (about USD 4.8 billion) to build its third bio campus in Songdo, Incheon, marking another step toward expanding its global biopharmaceutical production and advancing next-generation drug manufacturing technologies, as per a report by Pulse, the English service of Maeil Business News Korea.